ALK-POSITIVE NON-SMALL CELL LUNG CANCER
Clinical trials for ALK-POSITIVE NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ALK-POSITIVE NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ALK-POSITIVE NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise against tough lung cancer
Disease control Recruiting nowThis study tests a new daily pill, TRI-611, in adults with advanced ALK-positive non-small cell lung cancer. The first part finds the safest dose; the second checks how well it shrinks tumors in people who have already tried other ALK-targeting treatments. Participants take the d…
Matched conditions: ALK-POSITIVE NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: TRIANA Biomedicines, Inc. • Aim: Disease control
Last updated May 26, 2026 03:41 UTC
-
New program aims to ease emotional burden for advanced lung cancer patients
Symptom relief Recruiting nowThis study is testing a new supportive care program called POISE for people with stage IV non-small cell lung cancer who are on targeted therapy. The program includes four visits with a specially trained palliative care clinician to help patients cope with uncertainty and manage …
Matched conditions: ALK-POSITIVE NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 03:41 UTC